Utility of C-Reactive Protein for Cardiovascular Risk Stratification Across Three Age Groups in Subjects Without Existing Cardiovascular Diseases

American Journal of Cardiology

Volumn 104, Issue 4, 2009, Pages 538-542

  Hamer, Mark ^a   Chida, Yoichi ^a   Stamatakis, Emmanuel ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; FEMALE; FOLLOW UP; FRAMINGHAM RISK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; UNITED KINGDOM; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 67849125370     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.020     Document Type: Article

References (21)

1. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., and Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
2. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., and Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
3. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., Jacques P.F., Rifai N., Selhub J., Robins S.J., Benjamin E.J., D'Agostino R.B., and Vasan R.S. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006) 2631-2639
4. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 (2006) 21-29
5. Olsen M.H., Hansen T.W., Christensen M.K., Gustafsson F., Rasmussen S., Wachtell K., Ibsen H., Torp-Pedersen C., and Hildebrandt P.R. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 28 (2007) 1374-1381
6. Folsom A.R., Chambless L.E., Ballantyne C.M., Coresh J., Heiss G., Wu K.K., Boerwinkle E., Mosley Jr. T.H., Sorlie P., Diao G., and Sharrett A.R. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 166 (2006) 1368-1373
7. Sattar N., Murray H.M., McConnachie A., Blauw G.J., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., Jukema J.W., Kamper A.M., Macfarlane P.W., Murphy M.B., Packard C.J., Perry I.J., Stott D.J., Sweeney B.J., Twomey C., Westendorp R.G., Shepherd J., and PROSPER Study Group. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115 (2007) 981-989
8. de Ruijter W., Westendorp R.G., Assendelft W.J., den Elzen W.P., de Craen A.J., le Cessie S., and Gussekloo J. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338 (2009) a3083
9. Zethelius B., Berglund L., Sundström J., Ingelsson E., Basu S., Larsson A., Venge P., and Arnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358 (2008) 2107-2116
10. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
11. Kannel W.B. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11 (2002) 101-107
12. Hamer M., Molloy G.J., and Stamatakis E. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J Am Coll Cardiol 52 (2008) 2156-2162
13. The Scottish Government Statistics. Scottish Health Survey Publications. http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-health-survey/Publications Accessed November 2007
14. Information Services Division, NHS National Services Scotland. http://www.isdscotland.org Accessed February 2008
15. D'Agostino Sr. R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., and Kannel W.B. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (2008) 743-753
16. Olsen M.H., Hansen T.W., Christensen M.K., Gustafsson F., Rasmussen S., Wachtell K., Ibsen H., Torp-Pedersen C., and Hildebrandt P.R. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 26 (2008) 26-34
17. Woodward M., Brindle P., Tunstall-Pedoe H., and SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 93 (2007) 172-176 2007
18. Lawlor D.A., Harbord R.M., Timpson N.J., Lowe G.D., Rumley A., Gaunt T.R., Baker I., Yarnell J.W., Kivimäki M., Kumari M., Norman P.E., Jamrozik K., Hankey G.J., Almeida O.P., Flicker L., Warrington N., Marmot M.G., Ben-Shlomo Y., Palmer L.J., Day I.N., Ebrahim S., and Smith G.D. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS ONE 3 (2008) e3011
19. Pai J.K., Mukamal K.J., Rexrode K.M., and Rimm E.B. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 3 (2008) e1395
20. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., and Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45 (2004) 1169-1196
21. Simons L.A., Simons J., Friedlander Y., and McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 159 (2001) 201-208